MedPath
HSA Approval

CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial

SIN07168P

CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial

CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial

October 8, 1992

DUOPHARMA (SINGAPORE) PTE LTD

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD
Licence HolderDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01CF02

cloxacillin

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

LABORATOIRES PANPHARMA

Active Ingredients

CLOXACILLIN SODIUM EQV CLOXACILLIN

500 mg/vial

Cloxacillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial - HSA Approval | MedPath